Point72 Asset Management, L.P. 13D and 13G filings for Cidara Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 10:02 am Sale | 2023-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 62,511 1.400% | -130,889 (-67.68%) | Filing |
| 2023-02-14 4:23 pm Sale | 2022-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 193,400 5.400% | -22,502 (-10.42%) | Filing |
| 2022-02-14 4:41 pm Purchase | 2021-12-31 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 215,902 6.500% | 5,902 (+2.81%) | Filing |
| 2021-10-14 5:12 pm Purchase | 2021-10-13 | 13G | Cidara Therapeutics, Inc. CDTX | Point72 Asset Management, L.P. | 210,000 6.300% | 210,000 (New Position) | Filing |